Home › Funds › Cliffwater LLC › XERS
Cliffwater LLC position in XERS
XERIS BIOPHARMA HOLDINGS INC · Health Care
Cliffwater LLC reported holding 263,158 shares of XERS (XERIS BIOPHARMA HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$2.5M, representing 0.75% of its reported portfolio and ranking #13 among its reported holdings. Cliffwater LLC has disclosed XERS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Cliffwater LLC's XERS position evolved
Cliffwater LLC first disclosed a stake in XERS in Q2 2026 at 263,158 shares (US$2.1M). The position peaked in Q3 2026 at 263,158 shares, worth US$2.5M. Across 2 filings, Cliffwater LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 263,158 shares valued at US$2.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 263.16K | $2.08M | New |
| Q3 2026 | 263.16K | $2.52M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About XERS and 13F data
XERS (XERIS BIOPHARMA HOLDINGS INC) is a Health Care company. 52 other funds we track also report a position in XERS — the largest reported positions include CAPSTONE INVESTMENT ADVISORS, LLC (US$62.6M), Polar Asset Management Partners Inc. (US$28.8M), Rosalind Advisors, Inc. (US$23.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding XERS
- CAPSTONE INVESTMENT ADVISORS, LLC 23.07M sh · $62.64M · Q2 2026
- Polar Asset Management Partners Inc. 10.50M sh · $28.80M · Q2 2026
- Rosalind Advisors, Inc. 2.91M sh · $23.04M · Q2 2026
- Parkman Healthcare Partners LLC 1.81M sh · $14.32M · Q2 2026
- Vilga Financial Planning LLC 1.06M sh · $10.13M · Q3 2026
- Ishara Investments LP 1.23M sh · $9.74M · Q2 2026
- Knott David M Jr 1.00M sh · $9.59M · Q3 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 693.26K sh · $6.63M · Q3 2026
More on Cliffwater LLC
FAQ
How long has Cliffwater LLC held XERS?
Cliffwater LLC has disclosed XERS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Cliffwater LLC's current position in XERS?
As of Q3 2026, Cliffwater LLC holds 263.16K shares of XERS (XERIS BIOPHARMA HOLDINGS INC), valued at $2.52M, representing 0.75% of its reported portfolio and ranking #13.
Has Cliffwater LLC been buying or selling XERS?
In the latest 13F filing (Q3 2026), Cliffwater LLC held unchanged its position in XERS. The position peaked in Q3 2026 at 263.16K shares.
Which other funds hold XERS?
Other major institutional holders of XERS include CAPSTONE INVESTMENT ADVISORS, LLC, Polar Asset Management Partners Inc., Rosalind Advisors, Inc., among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.